Kangmei Pharma | 600518 - Pre Tax Profit


Kangmei Pharma reported CNY-14.01M in Pre-Tax Profit for its fiscal quarter ending in March of 2026.





Pre Tax Profit Change Date
Akebia Therapeutics USD -11.24M 12.39M Dec/2025
Alaunos Therapeutics USD -7.84M 633K Dec/2023
Avita Medical AUD -11.64M 12.13M Dec/2025
Cspc Pharmaceutical CNY 505.59M 706M Dec/2025
Dianthus Therapeutics USD -40.83M 23.6M Mar/2026
Genomma Lab Internacional MXN 534.73M 109.37M Jun/2026
Hypermarcas BRL 276.14M 163.07M Mar/2026
Ionis Pharmaceuticals USD -114M 21M Jun/2026
IQVIA Holdings USD 301M 5.92B Jun/2026
Jiangsu Hengrui CNY 2.4B 161.31M Jun/2026
Kangmei Pharma CNY -14.01M 16.08M Mar/2026
Moderna USD -1.33B 535M Mar/2026
Organon & Co USD 183M 30M Jun/2026
Revvity USD 187.24M 137.25M Jun/2026
Sh Fosun Pharma CNY 1.36B 82.9M Mar/2026
Tectonic Therapeutic USD -18.97M 63K Dec/2025
Viatris USD -247.3M 95.7M Mar/2026
Wuxi Apptec CNY 7.91B 2.3B Jun/2026
Xeris Pharmaceuticals USD 2.23M 8.85M Mar/2026
Zz Pientze Pharmaceu CNY 876.07M 352.96M Mar/2026